Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

NASDAQ:MYRG - Nasdaq - US55405W1045 - Common Stock - Currency: USD

191.94  -0.09 (-0.05%)

After market: 191.94 0 (0%)

Fundamental Rating

5

MYRG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 49 industry peers in the Construction & Engineering industry. While MYRG has a great health rating, there are worries on its profitability. MYRG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MYRG was profitable.
In the past year MYRG had a positive cash flow from operations.
Each year in the past 5 years MYRG has been profitable.
In the past 5 years MYRG always reported a positive cash flow from operatings.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

MYRG has a Return On Assets (2.28%) which is in line with its industry peers.
The Return On Equity of MYRG (6.31%) is comparable to the rest of the industry.
MYRG has a Return On Invested Capital of 5.07%. This is comparable to the rest of the industry: MYRG outperforms 51.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MYRG is significantly below the industry average of 16.67%.
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROIC 5.07%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.02%, MYRG is in line with its industry, outperforming 42.86% of the companies in the same industry.
MYRG's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.71%, MYRG is not doing good in the industry: 63.27% of the companies in the same industry are doing better.
MYRG's Operating Margin has declined in the last couple of years.
The Gross Margin of MYRG (8.90%) is worse than 71.43% of its industry peers.
MYRG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

7

2. Health

2.1 Basic Checks

MYRG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MYRG has less shares outstanding than it did 1 year ago.
MYRG has less shares outstanding than it did 5 years ago.
MYRG has a worse debt/assets ratio than last year.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MYRG has an Altman-Z score of 4.74. This indicates that MYRG is financially healthy and has little risk of bankruptcy at the moment.
MYRG has a better Altman-Z score (4.74) than 73.47% of its industry peers.
The Debt to FCF ratio of MYRG is 0.90, which is an excellent value as it means it would take MYRG, only 0.90 years of fcf income to pay off all of its debts.
MYRG has a better Debt to FCF ratio (0.90) than 83.67% of its industry peers.
MYRG has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.15, MYRG belongs to the top of the industry, outperforming 81.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Altman-Z 4.74
ROIC/WACC0.47
WACC10.68%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MYRG has a Current Ratio of 1.31. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
MYRG has a Current ratio (1.31) which is comparable to the rest of the industry.
A Quick Ratio of 1.31 indicates that MYRG should not have too much problems paying its short term obligations.
MYRG's Quick ratio of 1.31 is fine compared to the rest of the industry. MYRG outperforms 61.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

MYRG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.52%.
Measured over the past years, MYRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.67% on average per year.
Looking at the last year, MYRG shows a decrease in Revenue. The Revenue has decreased by -7.33% in the last year.
The Revenue has been growing by 10.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%

3.2 Future

The Earnings Per Share is expected to grow by 45.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.94% on average over the next years.
EPS Next Y98.62%
EPS Next 2Y55.25%
EPS Next 3Y45.56%
EPS Next 5YN/A
Revenue Next Year2.75%
Revenue Next 2Y4.43%
Revenue Next 3Y6.94%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 51.32 indicates a quite expensive valuation of MYRG.
Compared to the rest of the industry, the Price/Earnings ratio of MYRG is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.54, MYRG is valued quite expensively.
With a Price/Forward Earnings ratio of 23.35, MYRG is valued on the expensive side.
MYRG's Price/Forward Earnings is on the same level as the industry average.
MYRG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 51.32
Fwd PE 23.35
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MYRG.
MYRG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MYRG is cheaper than 61.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.94
EV/EBITDA 24.82
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYRG's earnings are expected to grow with 45.56% in the coming years.
PEG (NY)0.52
PEG (5Y)5.92
EPS Next 2Y55.25%
EPS Next 3Y45.56%

0

5. Dividend

5.1 Amount

MYRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (7/18/2025, 8:00:01 PM)

After market: 191.94 0 (0%)

191.94

-0.09 (-0.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners102.9%
Inst Owner Change-0.5%
Ins Owners1.75%
Ins Owner Change2.83%
Market Cap2.98B
Analysts85.45
Price Target186.05 (-3.07%)
Short Float %4.31%
Short Ratio3.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.89%
Min EPS beat(2)18.63%
Max EPS beat(2)39.15%
EPS beat(4)4
Avg EPS beat(4)56.53%
Min EPS beat(4)18.63%
Max EPS beat(4)84.18%
EPS beat(8)5
Avg EPS beat(8)26.57%
EPS beat(12)7
Avg EPS beat(12)22.39%
EPS beat(16)11
Avg EPS beat(16)20.01%
Revenue beat(2)1
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)3.99%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)3.99%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)8
Avg Revenue beat(12)3.22%
Revenue beat(16)11
Avg Revenue beat(16)3%
PT rev (1m)11.79%
PT rev (3m)20.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.67%
EPS NY rev (1m)0%
EPS NY rev (3m)9.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE 51.32
Fwd PE 23.35
P/S 0.88
P/FCF 29.94
P/OCF 18.31
P/B 5.43
P/tB 8.25
EV/EBITDA 24.82
EPS(TTM)3.74
EY1.95%
EPS(NY)8.22
Fwd EY4.28%
FCF(TTM)6.41
FCFY3.34%
OCF(TTM)10.48
OCFY5.46%
SpS217.81
BVpS35.35
TBVpS23.27
PEG (NY)0.52
PEG (5Y)5.92
Profitability
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROCE 7.36%
ROIC 5.07%
ROICexc 5.14%
ROICexgc 6.79%
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
FCFM 2.94%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexcg growth 3Y-34.99%
ROICexcg growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score4
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Debt/EBITDA 0.69
Cap/Depr 96.44%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 132.09%
Profit Quality 287.28%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 4.74
F-Score4
WACC10.68%
ROIC/WACC0.47
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
EPS Next Y98.62%
EPS Next 2Y55.25%
EPS Next 3Y45.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%
Revenue Next Year2.75%
Revenue Next 2Y4.43%
Revenue Next 3Y6.94%
Revenue Next 5YN/A
EBIT growth 1Y-52.55%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year383.08%
EBIT Next 3Y83.95%
EBIT Next 5YN/A
FCF growth 1Y-1.05%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y-11.17%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%